BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8688400)

  • 1. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol.
    Webster D; Penney GC; Templeton A
    Br J Obstet Gynaecol; 1996 Jul; 103(7):706-9. PubMed ID: 8688400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.
    Ashok PW; Templeton A
    Br J Obstet Gynaecol; 1999 Jul; 106(7):706-10. PubMed ID: 10428528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Bartley J; Baird DT
    BJOG; 2002 Nov; 109(11):1290-4. PubMed ID: 12452468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
    Mentula M; Suhonen S; Heikinheimo O
    Hum Reprod; 2011 Oct; 26(10):2690-7. PubMed ID: 21798991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Abbas DF; Blum J; Ngoc NT; Nga NT; Chi HT; Martin R; Winikoff B
    Obstet Gynecol; 2016 Nov; 128(5):1077-1083. PubMed ID: 27741182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial.
    Grimes DA; Smith MS; Witham AD
    BJOG; 2004 Feb; 111(2):148-53. PubMed ID: 14723752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
    el-Refaey H; Templeton A
    Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical methods for mid-trimester termination of pregnancy.
    Wildschut H; Both MI; Medema S; Thomee E; Wildhagen MF; Kapp N
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD005216. PubMed ID: 21249669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol.
    Jain JK; Meckstroth KR; Mishell DR
    Am J Obstet Gynecol; 1999 Dec; 181(6):1386-91. PubMed ID: 10601917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
    Ho PC; Chan YF; Lau W
    Contraception; 1996 May; 53(5):281-3. PubMed ID: 8724617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.